Diagnosis and secondary prevention measures in patients hospitalized for cerebral infarction in Spain. The DIAPRESIC study;Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC

Medicina Clinica

Volumn 131, Issue 20, 2008, Pages 765-769

  Gil Núñez, Antonio ^a   Vivancos, José ^b   Gabriel, Rafael ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cerebral infarction; Diagnosis; Secondary prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIURETIC AGENT; DOXAZOSIN; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; RATING SCALE; RISK FACTOR; SPAIN;

AGED; CEREBRAL INFARCTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; SECONDARY PREVENTION; SPAIN;

EID: 63149163469     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/S0025-7753(08)75500-3     Document Type: Article

References (26)

1. Instituto Nacional de Estadística. Defunciones según la causa de muerte 2002. Disponible en: http://www.ine.es
2. Adams R.J., Chimowitz M.I., Alpert J.S., Awad I.A., Cerqueria M.D., Fayad P., et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 34 (2003) 2310-2322
3. Rothwell P.M., Coull A.J., Giles M.F., Howard S.C., Silver L.E., Bull L.M., et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363 (2004) 1925-1933
4. Díez Tejedor E., and Por el Comité del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento y prevención del ictus 2002. Neurología 17 Supl 3 (2002) 1-105
5. Díez Tejedor E., Blanca B., Gil Núñez A., Gil Peralta A., and Matías Guiu J. Guía para el tratamiento preventivo del ictus. Neurología 17 Supl 3 (2002) 61-75
6. Wolf P.A., Clagett G.P., Easton J.D., Goldstein L.B., Gorelick P.B., Kelly-Hayes M., et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30 (1999) 1991-1994
7. Leys D., Kwiecinsky H., Bogousslavsky J., Bath P., Brainin M., Diener H.C., et al., For the EUSI Executive Committee and the EUSI Writing Committee. Prevention. Cerebrovasc Dis 17 Suppl 2 (2004) 15-29
8. Sappok T., Faulstich A., Stuckert E., Kruck H., Marx P., and Koennecke H.-.C. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 32 (2001) 1884-1889
9. Hamann G., Weimar C., Glahn J., Busse O., and Diener H.C. Adherence to secondary stroke prevention strategies - results from the German Stroke Data Bank. Cerebrovasc Dis 15 (2003) 282-288
10. Rudd A.G., Lowe D., Hoffman A., Irwin P., and Pearson M. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke. Age Ageing 33 (2004) 280-286
11. Volpato S., Maraldi C., Blè A., Ranzini M., Atti A.R., Domínguez L.J., et al. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA Study. Stroke 35 (2004) 913-917
12. Filippi A., Bignamini A.A., Sessa E., Samani F., and Mazzaglia G. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 34 (2003) 1010-1014
13. Hillen T., Dundas R., Lawrence E., Stewart J.A., Rudd A.G., and Wolfe C.D. Anti-thrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke 31 (2000) 469-475
14. Amar J., Cambou J.P., Touzé E., Bongard V., Jullien G., Vahanian A., et al., On behalf of ECLAT1 Study Investigators. Comparison of hypertension management after stroke and myocardial infarction: results from ECLAT1 - A French nationwide study. Stroke 35 (2004) 1579-1583
15. Joseph L.N., Babikian V.L., Allen N.C., and Winter M.R. Risk factor modification in stroke prevention. The experience of a stroke clinic. Stroke 30 (1999) 16-20
16. Mouradian M., Majumdar S.R., Senthilselvan A., Khan K., and Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?. Stroke 33 (2002) 1656-1659
17. Castillo J., Barrios V., Ros E., and Llobet X. Guidelines for action and diagnosis in atherothrombosis in Spain: ADA Study (Action and Diagnosis in Atherothrombosis). Rev Clin Esp 202 (2002) 202-208
18. Conthe Gutiérrez P., Lobos Bejarano J.M., González Juanatey J.R., Gil Núñez A., Pajuelo Fernández F.J., Novials Sarda A., and Investigadores del estudio ESPERANZA. Diferencias en la atención de las mujeres con alto riesgo cardiovascular respecto a los varones: estudio multidisciplinario. Med Clin (Barc) 120 (2003) 451-455
19. Duffy B.K., Phillips P.A., Davis S.M., Donnan G.A., Vedadhaghi M.E., and On behalf of the Stroke in Hospitals: an Australian Review of Treatment (START) Investigators. Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust 178 (2003) 318-323
20. Kapral M.K., Laupacis A., Phillips S.J., Silver F.L., Hill M.D., Fang J., et al. Investigators of the Registry of the Canadian Stroke Network. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke 35 (2004) 1756-1762
21. Reeves M.J., Arora S., Broderick J.P., Frankel M., Heinrich J.P., Hickenbottom S., et al. The Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36 (2005) 1232-1240
22. Gibbs R.G.J., Newson R., Lawrenson R., Greenhalgh R.M., and Davies A.H. Diagnosis and management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke 32 (2001) 1085-1090
23. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
24. Gil Núñez A., and Vivancos Mora J. Organization of medical care in acute stroke. The importance of a good network. Cerebrovasc Dis 17 Suppl 1 (2004) 113-123
25. Ovbiagele B., Saver J.L., Fredieu A., Suzuki S., Mc- Nair N., Dandekar A., et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 63 (2004) 1217-1222
26. Moreno Palanco M.A., Ciria de Pablo C., Ibáñez Sanz P., Sánchez Luis C., Pizarro Portillo C., and Suárez Fernández C. Reducción de la morbimortalidad cardiovascular tras un episodio cardiovascular agudo mediante el tratamiento intensivo de los factores de riesgo (proyecto MIRVAS). Med Clin (Barc) 129 (2007) 141-146